UPDATE : Monday, September 7, 2020
상단여백
Acute leukemia drug shows toxicity increase to particular genes
The Ministry of Food and Drug Safety said Monday it would add precautions o...
by Lee Hye-seon  |  2018-09-18 14:54
라인
AnC Bio, N&N Pharmaceuticals receive administrative warning
The Ministry of Food and Drug Safety said it has given an administrative wa...
by Lee Hye-seon  |  2018-09-17 14:59
라인
Philips reports reboot error in defibrillators
Philips said it has found a reboot error in some Efficia DFM100 defibrillat...
by Lee Hye-seon  |  2018-09-17 13:39
라인
Yuhan markets high-dose copy of Agrylin
Yuhan Corp. is to roll out a high-dose generic drug of Agrylin Cap. (ingred...
by Lee Hye-seon  |  2018-09-14 13:42
라인
Astellas wins nod for phase-3 trial on gastric cancer treatment
Astellas has obtained the regulatory approval to go ahead with a global pha...
by Lee Hye-seon  |  2018-09-11 10:38
라인
Pfizer Korea ordered to suspend imports of 3 drugs for poor quality control
The government has ordered Pfizer Korea to halt imports of three drugs for ...
by Lee Hye-seon  |  2018-09-07 16:24
라인
Biopharmaceuticals lead Korea’s drug output growth
Korea’s pharmaceutical output has exceeded 20 trillion won ($17.8 billion) ...
by Lee Hye-seon  |  2018-09-07 13:47
라인
Antihypertensive drug Kanarb tops output among local new drugs
Boryung Pharmaceutical’s antihypertensive treatment Kanarb marked the large...
by Lee Hye-seon  |  2018-09-07 11:08
라인
Antidiabetic combo Steglujan approved in Korea
MSD Korea said it has won approval to sell an antidiabetic combination drug...
by Lee Hye-seon  |  2018-09-06 11:55
라인
Korea to ban BPA in all food containers for children
The Korean government said it would prohibit the use of bisphenol A (BPA) i...
by Lee Hye-seon  |  2018-08-31 15:46
라인
Myungmoon Pharm’s valsartan additionally suspended
The government said it has completed testing all valsartan-using hypertensi...
by Lee Hye-seon  |  2018-08-23 15:10
라인
Lixiana faces patent challenge in substance, composition
Daiichi Sankyo’s anticoagulant treatment Lixiana (ingredient: edoxaban) has...
by Lee Hye-seon  |  2018-08-22 11:16
라인
TPLUS’ picture archiving system wins European certification
TPLUS, a Korean healthcare solution provider, said it has obtained Europe’s...
by Lee Hye-seon  |  2018-08-20 14:40
라인
MSD wins nod for antidiabetic SGLT-2 inhibitor
The Korean government has approved MSD’s Steglatro (ingredient: ertuglifloz...
by Lee Hye-seon  |  2018-08-20 11:34
라인
2 pharmaceuticals ordered to halt import drugs for poor packaging
Pfizer Korea and Bristol-Meyers Squibb Pharmaceutical Korea faced a one-mon...
by Lee Hye-seon  |  2018-08-17 15:10
라인
Psoriasis drug Tremfya may add indication for Crohn’s disease
Janssen Korea has obtained approval for clinical trials on plaque psoriasis...
by Lee Hye-seon  |  2018-08-14 12:07
라인
13 gadolinium contrast agents banned until year-end
The government said it would ban 13 linear gadolinium contrast agents used ...
by Lee Hye-seon  |  2018-08-13 14:36
라인
JW to launch drug combining Livaro, Ezetimibe
JW Pharmaceuticals has begun to develop a drug which combines two dyslipide...
by Lee Hye-seon  |  2018-08-09 11:59
라인
‘Peritoneal dialysis more cost-effective than hemodialysis’
Peritoneal dialysis (PD) is more cost-effective than hemodialysis (HD) for ...
by Lee Hye-seon  |  2018-07-23 11:53
라인
Il-yang gets 1-month suspension on quadrivalent flu vaccine
The government has suspended Il-yang Pharmaceutical’s manufacturing of Tera...
by Lee Hye-seon  |  2018-07-20 14:58
여백
여백
여백
Back to Top